Clinical Study

Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia

Table 2

Baseline biochemical and hematological parameters of the study cohort.

Roma (mean ± SD)Non-Roma (mean ± SD)

ALT (µkat/L)1.52 ± 1.47431.62 ± 1.22460.703
GGT (µkat/L)0.90 ± 0.64431.06 ± 1.15460.977
TC (mmol/L)4.90 ± 0.90435.10 ± 0.95430.478
LDL-C (mmol/L)3.00 ± 0.60223.14 ± 0.87350.605
TAG (mmol/L)2.37 ± 4.72271.26 ± 0.69430.167
HDL-C (mmol/L)1.18 ± 0.30251.47 ± 0.36440.003
Bilirubin (µmol/L)11.95 ± 5.774313.70 ± 6.75460.349
Albumin (g/L)46.91 ± 4.444345.24 ± 3.55460.176
Platelets (109/L)201.40 ± 60.0543198.82 ± 65.29450.754
WBC (109/L)6.43 ± 2.28436.03 ± 1.46450.628

ALT: alanine aminotransferase, GGT: gamma-glutamyl transferase, TC: total cholesterol, LDL-C: low density lipoproteins, TAG: triacylglycerols, HDL-C: high density lipoproteins, and WBC: white blood cells.